New

Human Liver Models Market

2021

Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Other), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

Publication Month: Oct 2021 | Report Code: TIPRE00025128 | No. of Pages: 178 | Category: Biotechnology | Status: Published

Market Insights

Human Liver Models Market to Grow at a CAGR of 11.7% to reach US$ 508.26 million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The human liver models market is projected to reach US$ 508.26 million by 2028 from US$ 233.90 million in 2021; it is expected to grow at a CAGR of 11.7% from 2021 to 2028.

The market's growth is primarily attributed to the increasing prevalence of liver diseases and the growing focus on developing alternatives for animal testing models. However, the high costs of human liver models and issues with incorporating liver models into existing workflow are hindering the Human Liver Models market growth. The liver is an important organ that performs vital body functions such as synthesis of blood clotting factors, bile production, protein production, and detoxification. Human liver models are used to study the drug's toxicity and enable understanding of the effect of drugs and the progression of liver disease. The rising focus on developing alternatives for the animal testing models is one of the major factors estimated to encourage the growth of the global human liver models in the next few years.

Strategic Insights

The Asia Pacific biopharmaceutical industry was disturbed for a few months of 2020, owing to the COVID-19 outbreak. The COVID-19 pandemic has affected clinical trials in an unparalleled manner due to multiple levels of restrictions imposed to control the spread of infection. However, with the rising demand for products to treat the COVID-19 infection, the biopharmaceutical and pharmaceutical companies in India and China have increased their research activities, which is positively impacting the market growth.

Lucrative Regions for Human Liver Models Market

Lucrative Regions for Human Liver Models Market

Get more information on this report :



Market Insights

Increasing Prevalence of Liver Diseases Fuel Human Liver Models Market Growth

The liver is the largest internal organ in the human body and performs over 500 functions. Liver toxicity is a major concern in risk assessment as the liver is exposed to most xenobiotic compounds and their bioactive metabolites, making it susceptible to chemically induced liver disease. Hepatitis C virus (HCV), chronic hepatitis B virus (HBV), nonalcoholic fatty liver disease (NAFLD), and alcohol-associated liver disease (ALD) are among the leading causes of chronic liver disease. Viral hepatitis continues to be the leading cause of death cases caused by liver failure, and at the same time, the NAFLD has become one of the fastest-growing contributors to liver morbidity and associated mortality. According to the national statistics of the UK, liver diseases have been ranked the fifth-leading cause of death in the country.

Furthermore, these diseases are considered the second-leading cause of death among all digestive diseases in the US. According to the American Association for the Study of Liver Diseases, in 2017, the global burden of liver cancer and cirrhosis had increased. The NAFLDs have an estimated prevalence of ~25% in the general population. Nearly a third of the US population has the NAFLD, and people with Type 2 diabetes mellitus or obesity are disproportionately affected; the number of cases with NAFLD is expected to increase from 83.1 million people in 2015 to 100.9 million by 2030. Thus, a rise in the global prevalence of liver diseases, including chronic and acute diseases and microbial infections, increases the demand for liver models.

Type-Based Insights

Based on type, the human liver models market is further segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment holds the largest share of the market. However, the liver-on-a-chip segment is anticipated to register the highest CAGR during 2021–2028. Advances in liver organoid technology provide models for prenatal development, tissue preservation, and pathologies, which would propel the market growth of this segment in the coming years.

Human Liver Models Market, by Type – 2021 and 2028

Human Liver Models Market, by Type – 2021 and 2028

Get more information on this report :



Application-Based Insights

Based on application, the human liver models market is further segmented into educational, drug discovery, and others. The drug discovery segment holds the largest share of the human liver models market; however, the educational segment is anticipated to register the highest CAGR during the forecast period.

End User-Based Insights

Based on end user, the human liver models market is segmented into research institutes, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology companies segment holds the largest market share. However, the research institutes segment is estimated to register the highest CAGR during the forecast period. The projected market growth for this segment can be attributed to an increase in collaborations between industry and universities for genome research and technological advances in the production of human liver models.

Companies operating in the human liver models market are adopting product innovations strategy to meet the evolving customer demands worldwide, which also permits them to maintain their brand name in the global market.

Human Liver Models Market – by Type

  • Liver Organoids
  • Liver-on-a-chip
  • 2D Models
  • 3D Bioprinting
  • Others

Human Liver Models Market – by Application

  • Drug Discovery
  • Educational
  • Other

Human Liver Models Market – by End User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Others

Human Liver Models Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • THERMO FISHER SCIENTIFIC INC.
  • Emulate, Inc.
  • CN Bio Innovations,
  • CYFUSE BIOMEDICAL K.K.
  • MIMETAS BV
  • InSphero
  • BioIVT
  • CELLINK
  • Kerafast
  • Cyprio
  • Kirkstall
  • ORGANOVO HOLDINGS INC

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Human Liver Models Market – By Type

1.3.2 Global Human Liver Models Market – By Application

1.3.3 Global Human Liver Models Market – By End User

1.3.4 Global Human Liver Models Market – By Geography

2. Global Human Liver Models Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Human Liver Models Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Experts Opinion

5. Human Liver Models Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Liver Diseases

5.1.2 Growing Focus on Developing Alternatives for Animal Testing

5.2 Market Restraints

5.2.1 High Cost of Liver Models

5.2.2 Issues with Incorporation of Liver Models into Existing Workflow

5.3 Market Opportunities

5.3.1 Strong Focus on Drug Discovery Activities

5.4 Future Trends

5.4.1 Technological Advancements in Organ Printing

5.1 Impact analysis

6. Human Liver Models Market – Global Analysis

6.1 Global Human Liver Models Market Revenue Forecast and Analysis

6.2 Global Human Liver Models Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Human Liver Models Market Analysis – By Type

7.1 Overview

7.2 Human Liver Models Market Revenue Share, by Type (2021 and 2028)

7.3 Liver Organoids

7.3.1 Overview

7.3.2 Liver Organoids: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

7.4 Liver-on-a-chip

7.4.1 Overview

7.4.2 Liver-on-a-chip: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

7.5 2D Models

7.5.1 Overview

7.5.2 2D Models: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

7.6 3D Bioprinting

7.6.1 Overview

7.6.2 3D Bioprinting: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

7.7 Others

7.7.1 Overview

7.7.2 Others: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

8. Human Liver Models Market Analysis – By Application

8.1 Overview

8.2 Human Liver Models Market Share, by Application, 2021 and 2028, (%)

8.3 Educational

8.3.1 Overview

8.3.2 Educational: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

8.4 Drug Discovery

8.4.1 Overview

8.4.2 Drug Discovery: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

8.5 Other

8.5.1 Overview

8.5.2 Other: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

9. Human Liver Models Market Analysis – By End User

9.1 Overview

9.2 Human Liver Models Market Share, by End User, 2021 and 2028, (%)

9.3 Research Institutes

9.3.1 Overview

9.3.2 Research Institutes: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

9.4 Pharmaceutical and Biotechnology Companies

9.4.1 Overview

9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

9.5 Others

9.5.1 Overview

9.5.2 Others: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

10. Global Human Liver Models Market – Geographic Analysis

10.1 North America: Human Liver Models Market

10.1.1 Overview

10.1.2 North America: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.3 North America: Human Liver Models Market, by Type, 2019–2028 (US$ Thousand)

10.1.4 North America: Human Liver Models Market, by Application, 2019–2028 (US$ Thousand)

10.1.5 North America: Human Liver Models Market, by End User, 2019–2028 (US$ Thousand)

10.1.6 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)

10.1.6.1 US: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.1.1 US: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.1.2 US: Human Liver Models Market, by Type, 2019–2028 (US$ Thousand)

10.1.6.1.3 US: Human Liver Models Market, by Application, 2019–2028 (US$ Thousand)

10.1.6.1.4 US: Human Liver Models Market, by End User, 2019–2028 (US$ Thousand)

10.1.6.2 Canada: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.2.1 Canada: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.2.2 Canada: Human Liver Models Market, by Type, 2019–2028 (US$ Thousand)

10.1.6.2.3 Canada: Human Liver Models Market, by Application, 2019–2028 (US$ Thousand)

10.1.6.2.4 Canada: Human Liver Models Market, by End User, 2019–2028 (US$ Thousand)

10.1.6.3 Mexico: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.3.1 Mexico: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.6.3.2 Mexico: Human Liver Models Market, by Type– 2019–2028 (US$ Thousand)

10.1.6.3.3 Mexico: Human Liver Models Market, by Application – 2019–2028 (US$ Thousand)

10.1.6.3.4 Mexico: Human Liver Models Market, by End User, 2019–2028 (US$ Thousand)

10.2 Europe: Human Liver Models Market

10.2.1 Overview

10.2.2 Europe: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.3 Europe: Human Liver Models Market, by Type– Revenue and Forecast to 2028 (USD Thousand)

10.2.4 Europe: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.5 Europe: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6 Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)

10.2.6.1 Germany: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.1.1 Germany: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.1.2 Germany: Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.1.3 Germany: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.1.4 Germany: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.2 France: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.2.1 France: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.2.2 France: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.2.3 France: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.2.4 France: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.3 UK: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.3.1 UK: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.3.2 UK: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.3.3 UK: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.3.4 UK: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.4 Spain: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.4.1 Spain: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.4.2 Spain: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.4.3 Spain: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.4.4 Spain: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.5 Italy: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.5.1 Italy: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.5.2 Italy: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.5.3 Italy: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.5.4 Italy: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.6 Rest of Europe: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.6.1 Rest of Europe: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.6.2 Rest of Europe: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.6.3 Rest of Europe: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.2.6.6.4 Rest of Europe: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.3 Asia Pacific: Human Liver Models Market

10.3.1 Overview

10.3.2 Asia Pacific: Human Liver Models Market - Revenue and Forecast to 2028 (USD Thousand)

10.3.3 Asia Pacific: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.4 Asia Pacific: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.5 Asia Pacific: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6 Asia Pacific: Human Liver Models Market, by Country, 2021 & 2028 (%)

10.3.6.1 China: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.1.1 China: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.1.2 China: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.1.3 China: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.1.4 China: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6.2 Japan: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.2.1 Japan: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.2.2 Japan: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.2.3 Japan: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.2.4 Japan: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6.3 India: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.3.1 India: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.3.2 India: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.3.3 India: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.3.4 India: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6.4 Australia: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.4.1 Australia: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.4.2 Australia: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.4.3 Australia: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.4.4 Australia: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6.5 South Korea: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.5.1 South Korea: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.5.2 South Korea: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.5.3 South Korea: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.5.4 South Korea: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.3.6.6 Rest of Asia Pacific: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.6.1 Rest of Asia Pacific: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

10.3.6.6.2 Rest of Asia Pacific: Human Liver Models Market, by Type, 2019–2028 (USD Thousand)

10.3.6.6.3 Rest of Asia Pacific: Human Liver Models Market, By Application, 2019–2028 (USD Thousand)

10.3.6.6.4 Rest of Asia Pacific: Human Liver Models Market, by End User, 2019–2028 (USD Thousand)

10.4 Middle East & Africa Human Liver Models Market

10.4.1 Overview

10.4.2 Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.3 Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

10.4.4 Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

10.4.5 Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

10.4.6 Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Country (%)

10.4.6.1 UAE Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.1.1 UAE Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.1.2 UAE Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

10.4.6.1.3 UAE Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

10.4.6.1.4 UAE Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

10.4.6.2 Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.2.1 Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.2.2 Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

10.4.6.2.3 Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

10.4.6.2.4 Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

10.4.6.3 South Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.3.1 South Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.6.3.2 South Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

10.4.6.4 South Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

10.4.6.5 South Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

10.4.7 Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.7.1 Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

10.4.7.2 Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type (US$ Thousand)

10.4.7.3 Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

10.4.7.4 Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

10.5 South and Central America: Human Liver Models Market

10.5.1 Overview

10.5.2 South and Central America: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.3 South and Central America Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

10.5.4 South and Central America Human Liver Models Market, by Application– Revenue and Forecast to 2028 (US$ Thousand)

10.5.5 South and Central America Human Liver Models Market, by End User– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6 South and Central America: Human Liver Models Market, by Country, 2021 & 2028 (%)

10.5.6.1 Brazil: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.1.1 Overview

10.5.6.2 Brazil: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.2.1 Brazil Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.2.2 Brazil Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.2.3 Brazil Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.3 Argentina: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.3.1 Overview

10.5.6.3.2 Argentina: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.3.3 Argentina Human Liver Models Market, by Type- Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.3.4 Argentina Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.3.5 Argentina Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.4 Rest of South and Central America: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.4.1 Overview

10.5.6.4.2 Rest of South and Central America: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.4.3 Rest of South and Central America Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.4.4 Rest of South and Central America Human Liver Models Market, by Application– Revenue and Forecast to 2028 (US$ Thousand)

10.5.6.4.5 Rest of South and Central America Human Liver Models Market, by End User– Revenue and Forecast to 2028 (US$ Thousand)

11. Impact Of COVID-19 Pandemic on Human Liver Models Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment Of COVID-19 Pandemic

11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Human Liver Models Market–Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Company Profiles

13.1 THERMO FISHER SCIENTIFIC INC.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Emulate, Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 CN Bio Innovations

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 CYFUSE BIOMEDICAL K.K.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 MIMETAS BV

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 InSphero

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BioIVT

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 CELLINK

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Kerafast

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Cyprio

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

13.11 Kirkstall

13.11.1 Key Facts

13.11.2 Business Description

13.11.3 Products and Services

13.11.4 Financial Overview

13.11.5 SWOT Analysis

13.11.6 Key Developments

13.12 ORGANOVO HOLDINGS INC.

13.12.1 Key Facts

13.12.2 Business Description

13.12.3 Products and Services

13.12.4 Financial Overview

13.12.5 SWOT Analysis

13.12.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 2. North America Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 3. North America Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 4. US: Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 5. US: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 6. US Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 7. Canada Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 8. Canada Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 9. Canada Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 10. Mexico Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 11. Mexico Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 12. Mexico Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 13. Europe: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 14. Europe: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 15. Europe: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 16. Germany: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 17. Germany: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 18. Germany: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 19. France: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 20. France: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 21. France: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 22. UK: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 23. UK: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 24. UK: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 25. Spain: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 26. Spain: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 27. Spain: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 28. Italy: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 29. Italy: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 30. Italy: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 31. Rest of Europe: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (US$ Thousand)

Table 32. Rest of Europe: Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 33. Rest of Europe: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 34. Asia Pacific: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 35. Asia Pacific Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 36. Asia Pacific Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 37. China: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 38. China: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 39. China: Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 40. Japan: Human Liver Models Market, by Type– Revenue and Forecast to 2028 (USD Thousand)

Table 41. Japan: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 42. Japan: Human Liver Models Market, by End User – Revenue and Forecast to 2028 (USD Thousand)

Table 43. India: Human Liver Models Market, by Type– Revenue and Forecast to 2028 (USD Thousand)

Table 44. India: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 45. India: Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 46. Australia: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 47. Australia: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 48. Australia: Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 49. South Korea: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 50. South Korea: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 51. South Korea: Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 52. Rest of Asia Pacific: Human Liver Models Market, by Type – Revenue and Forecast to 2028 (USD Thousand)

Table 53. Rest of Asia Pacific: Human Liver Models Market, By Application – Revenue and Forecast to 2028 (USD Thousand)

Table 54. Rest of Asia Pacific: Human Liver Models Market, by End User– Revenue and Forecast to 2028 (USD Thousand)

Table 55. Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

Table 56. Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 57. Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 58. UAE Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

Table 59. UAE Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 60. UAE Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 61. Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

Table 62. Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 63. Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 64. South Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type(US$ Thousand)

Table 65. South Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 66. South Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 67. Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By Type (US$ Thousand)

Table 68. Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By Application (US$ Thousand)

Table 69. Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028, By End User (US$ Thousand)

Table 70. South and Central America Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 71. South and Central America Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 72. South and Central America Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 73. Brazil Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 74. Brazil Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 75. Brazil Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 76. Argentina Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 77. Argentina Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 78. Argentina Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 79. Rest of South and Central America Human Liver Models Market, by Type– Revenue and Forecast to 2028 (US$ Thousand)

Table 80. Rest of South and Central America Human Liver Models Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)

Table 81. Rest of South and Central America Human Liver Models Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)

Table 82. Organic Developments Done by Companies

Table 83. Inorganic Developments Done by Companies

Table 84. Glossary of Terms, Human Liver Models Market

LIST OF FIGURES

Figure 1. Human Liver Models Market Segmentation

Figure 2. Human Liver Models Market Segmentation, By Region

Figure 3. Global Human Liver Models Market Overview

Figure 4. Liver Organoids Held the Largest Share of the Type Segment in Human Liver Models Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Human Liver Models Market, by Geography (US$ Thousand)

Figure 7. Global Human Liver Models Market – Leading Country Markets (US$ Thousand)

Figure 8. Global Human Liver Models Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe and PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. Human Liver Models Market Impact Analysis of Drivers and Restraints

Figure 15. Global Human Liver Models Market – Revenue Forecast and Analysis – 2020- 2028

Figure 16. Global Human Liver Models Market – By Geography Forecast and Analysis – 2021- 2028

Figure 17. Market Positioning of Key Players in Global Human Liver Models Market

Figure 18. Human Liver Models Market Revenue Share, by Type (2021 and 2028)

Figure 19. Liver Organoids: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 20. Liver-on-a-chip: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 21. 2D Models: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 22. 3D Bioprinting: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 23. Others: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 24. Human Liver Models Market Share, by Application, 2021 and 2028 (%)

Figure 25. Educational: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 26. Drug Discovery: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 27. Other: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 28. Human Liver Models Market Share, by End User, 2021 and 2028 (%)

Figure 29. Research Institutes: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 30. Pharmaceutical and Biotechnology Companies: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 31. Others: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousands)

Figure 32. North America: Human Liver Models Market, by Key Country – Revenue (2021) (US$ Thousand)

Figure 33. North America Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 34. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)

Figure 35. US: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 36. Canada: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 37. Mexico: Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

Figure 38. Europe: Human Liver Models Market, by Key Country – Revenue (2021) (USD Thousand)

Figure 39. Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 40. Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)

Figure 41. Germany: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 42. France: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 43. UK: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 44. Spain: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 45. Italy: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 46. Rest of Europe: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 47. Asia Pacific: Human Liver Models Market, by Key Country – Revenue (2021) (USD Thousand)

Figure 48. Asia Pacific Human Liver Models Market Revenue and Forecast to 2028 (USD Thousand)

Figure 49. Asia Pacific: Human Liver Models Market, by Country, 2021 & 2028 (%)

Figure 50. China: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 51. Japan: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 52. India: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 53. Australia: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 54. South Korea: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 55. Rest of Asia Pacific: Human Liver Models Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 56. Middle East & Africa Human Liver Models Market Revenue Overview, by Country (2021) (US$ Thousand)

Figure 57. Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 58. Middle East & Africa Human Liver Models Market Revenue and Forecasts to 2028, By Country (%)

Figure 59. UAE Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 60. Saudi Arabia Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 61. South Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 62. Rest of Middle East and Africa Human Liver Models Market Revenue and Forecasts to 2028 (US$ Thousand)

Figure 63. South and Central America: Human Liver Models Market, by Key Country – Revenue (2021) (US$ Thousand)

Figure 64. South and Central America Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 65. South and Central America: Human Liver Models Market, by Country, 2021 & 2028 (%)

Figure 66. Brazil: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 67. Argentina: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 68. Rest of South and Central America: Human Liver Models Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 69. Impact of COVID-19 Pandemic in North American Country Markets

Figure 70. Impact of COVID-19 Pandemic in European Country Markets

Figure 71. Impact of COVID-19 Pandemic in European Country Markets

Figure 72. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 73. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

Figure 74. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Human Liver Models Market

  1. THERMO FISHER SCIENTIFIC INC.
  2. Emulate, Inc.
  3. CN Bio Innovations,
  4. CYFUSE BIOMEDICAL K.K.
  5. MIMETAS BV
  6. InSphero
  7. BioIVT
  8. CELLINK
  9. Kerafast
  10. Cyprio
  11. Kirkstall
  12. ORGANOVO HOLDINGS INC      
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the human liver models market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global human liver models market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00025128
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

The factors that are driving growth of the market are increasing prevalence of liver diseases, and growing focus on developing alternatives for animal testing models.

Various companies have made organic growth strategies in the human liver models market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as InSphero, Emulate, Inc amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

North America dominates the global human liver models market due to factors such as increasing incidences of the liver diseases such as cirrhosis, chronic liver disease (CLD), Nonalcoholic fatty liver disease (NAFLD) and others across the country. Moreover, the growth of market in Canada is expected to grow due to increasing support from the government to address the rising concerns about the liver diseases.

The liver-on-a-chip segment is growing at the highest CAGR owing to increasing demand for cost-effective alternatives to animal models for drug research and development.

Asia Pacific is expected to be the fastest growing region in the Human Liver Models market. The growth of the market in this region is primarily due to growing biopharmaceutical industry, increasing number of clinical trials, and increasing research activities for the development of innovative therapies.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.